These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15908977)
1. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Bengala C; Guarneri V; Ledermann J; Rosti G; Wandt H; Lotz JP; Cure JH; Orlandini C; Ferrante P; Conte PF; Demirer T; Bone Marrow Transplant; 2005 Jul; 36(1):25-31. PubMed ID: 15908977 [TBL] [Abstract][Full Text] [Related]
2. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit. Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S Breast J; 2006; 12(6):531-5. PubMed ID: 17238982 [TBL] [Abstract][Full Text] [Related]
3. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460 [TBL] [Abstract][Full Text] [Related]
4. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results. Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406 [TBL] [Abstract][Full Text] [Related]
5. High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Sweetenham JW; Taghipour G; Milligan D; Blystad AK; Caballero D; Fassas A; Goldstone AH Bone Marrow Transplant; 1997 Nov; 20(9):745-52. PubMed ID: 9384476 [TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G Bone Marrow Transplant; 2001 Mar; 27(5):511-5. PubMed ID: 11313685 [TBL] [Abstract][Full Text] [Related]
7. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
9. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654 [TBL] [Abstract][Full Text] [Related]
10. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Donato ML; Aleman A; Champlin RE; Saliba RM; Wharton JT; Burke TW; Bodurka DC; Bevers MW; Levenback CF; Wolf JK; Bast RC; Freedman RS; Ippoliti C; Brewer M; Gajewski JL; Gershenson DM Bone Marrow Transplant; 2004 Jun; 33(12):1219-24. PubMed ID: 15122311 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival. Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144 [TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999. Pedrazzoli P; Ferrante P; Kulekci A; Schiavo R; De Giorgi U; Carminati O; Marangolo M; Demirer T; Siena S; Rosti G; Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095 [TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution. Bertucci F; Viens P; Gravis G; Blaise D; Faucher C; Oziel-Taoeb S; Bardou VJ; Jacquemier J; Delpero JR; Maraninchi D Anticancer Res; 1999; 19(2B):1455-61. PubMed ID: 10365123 [TBL] [Abstract][Full Text] [Related]
14. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584 [TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Kim HJ; Bang SM; Lee J; Kwon HC; Suh C; Kim HJ; Lee JH; Ryoo BY; Park YH; Kwon JM; Oh SY; Lee HR; Kim K; Jung CW; Park K; Kim WS Bone Marrow Transplant; 2006 May; 37(9):819-24. PubMed ID: 16547486 [TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Fanin R; Ruiz de Elvira MC; Sperotto A; Baccarani M; Goldstone A Bone Marrow Transplant; 1999 Mar; 23(5):437-42. PubMed ID: 10100556 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours. El-Helw LM; Naik JD; Chester JD; Joffe JK; Selby PJ; Coleman RE BJU Int; 2006 Sep; 98(3):519-25. PubMed ID: 16925746 [TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results. Salerno MG; Ferrandina G; Greggi S; Pierelli L; Menichella G; Leone G; Scambia G; Mancuso S Bone Marrow Transplant; 2001 May; 27(10):1017-25. PubMed ID: 11438815 [TBL] [Abstract][Full Text] [Related]
19. High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Nadal E; Giné E; Bladé J; Esteve J; Rosiñol L; Fernández-Avilés F; Marin P; Martinez C; Rovira M; Urbano-Ispizua A; Carreras E; Montserrat E Bone Marrow Transplant; 2004 Jan; 33(1):61-4. PubMed ID: 14704657 [TBL] [Abstract][Full Text] [Related]
20. [Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]. Viens P; Bertucci F; Gravis G; Camerlo J; Cowen D; Delpero JR; Conte M; Jacquemier J; Faucher C; Blaise D; Bardou VJ; Chabannon C; Blanc AP; Jaubert D; Maraninchi D Bull Cancer; 1997 Sep; 84(9):869-76. PubMed ID: 9435808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]